Jun 17, 2026
10X Genomics (TXG) Stock Surges 4% Following Cleveland Clinic Bladder Cancer Research Agreement
10X Genomics (TXG) stock climbed 3.8% after revealing a Cleveland Clinic partnership for bladder cancer research using Flex Apex, Xenium, and Atera platforms.
The post 10X Genomics (TXG) Stock Surges 4% Following Cleveland Clinic Bladder Cancer Research Agreement appeared first on Blockonomi.
Source: Blockonomi →Related News
- 44 minutes ago
AST SpaceMobile (ASTS) Stock Plunges 50% — Is Now the Time to Buy?
- 46 minutes ago
Sadot (SDOT) Stock Soars 41% on $6M TradeIQ Acquisition and $200M Financing Pack...
- 52 minutes ago
Intuitive Surgical (ISRG) Stock Plunges 10% Despite Earnings Beat — Buy the Dip?
- 53 minutes ago
Semiconductor Sector Tumbles Into Bear Market as AI Optimism Fades
- 54 minutes ago
SK Hynix (SKHY) Plunges 13.7% Before Recovery — Analysts Still Project Double th...